Which glioblastoma patients will respond to immunotherapy? :

Northwestern Medicine scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas — the most common and

Related Keywords

Dinesh Jaishankar , Kirstenb Burdett , Joseph Shilati , Hui Zhang , Matthew Mccord , Daniel Zhang , Victor Arrieta , Christina Amidei , Li Chen , Amyb Heimberger , Catalina Lee Chang , Leead Cooper , Roger Stupp , Crismita Dmello , Rimasv Lukas , Adam Sonabend , Seong Jae Kang , Andrew Gould , Craig Horbinski , Jonathant Yamaguchi , National Cancer Institute , National Institutes Of Health , Roberth Lurie Comprehensive Cancer Center , Northwestern University , Northwestern University Feinberg School Of Medicine , National Institute Of Neurological Disorders , Northwestern Medicine , Northwestern University Feinberg School , Comprehensive Cancer Center , Bin Zhang , National Institutes , National Institute , Neurological Disorders , Translational Approaches ,